Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M612016-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,334.90 | |
M612016-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,000.90 |
Specifications & Purity | Moligand™ |
---|---|
Grade | Moligand™ |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
INCHI | InChI=1S/C23H21F4N5O3/c1-14(31-9-6-23(26,27)17(13-31)15-4-7-32(34)8-5-15)22(33)30-20-11-29-21(12-28-20)35-19-3-2-16(24)10-18(19)25/h2-5,7-8,10-12,14,17H,6,9,13H2,1H3,(H,28,30,33)/t14-,17+/m0/s1 |
---|---|
InChi Key | UOCITXUZOXOHLH-WMLDXEAASA-N |
Canonical SMILES | C[C@@H](C(=O)Nc1ncc(nc1)Oc1c(cc(cc1)F)F)N1CCC([C@H](C1)c1cc[n+](cc1)[O-])(F)F |
Isomeric SMILES | C[C@@H](C(=O)NC1=CN=C(C=N1)OC2=C(C=C(C=C2)F)F)N3CCC([C@H](C3)C4=CC=[N+](C=C4)[O-])(F)F |
PubChem CID | 164734529 |
PubChem CID | 164734529 |
---|
Enter Lot Number to search for COA:
1. Ogasawara H, Noguchi M. (2021) Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.. Cells, 10 (11): (589-97). [PMID:34831128] |
2. Numata T, Harada K, Nakae S. (2022) Roles of Mast Cells in Cutaneous Diseases.. Front Immunol, 13 (3): (923495). [PMID:35874756] |
3. Trier AM, Kim BS. (2022) Structural insights into MRGPRX2: A new vision of itch and allergy.. J Allergy Clin Immunol, 149 (4): (1221-1222). [PMID:35090947] |
4. Al Hamwi G, Riedel YK, Clemens S, Namasivayam V, Thimm DT, Müller CE. (2022) Mas-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs.. Pharmacol Ther, 129 (3): (108259). [PMID:35934214] |